-
1 Comment
Yixintang Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 15.3% below its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Yixintang Pharmaceutical Group Co., Ltd's total revenue rose by 21.3% to $3B since the same quarter in the previous year.
Its net income has increased by 55.1% to $186M since the same quarter in the previous year.
Finally, its free cash flow fell by 27.9% to $190M since the same quarter in the previous year.
Based on the above factors, Yixintang Pharmaceutical Group Co., Ltd gets an overall score of 3/5.
Exchange | SHE |
---|---|
CurrencyCode | CNY |
ISIN | CNE100001WJ8 |
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
Market Cap | 8B |
---|---|
Beta | 0.78 |
PE Ratio | 233.5 |
Target Price | 16.4503 |
Dividend Yield | None |
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. It operates stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities. It also sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002727.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025